Loading market dashboard
Virax Biolabs Group Limited
VRAXHealthcareNASDAQGB
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Virax Biolabs Group Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2027 | $4.0K | $4.0K - $4.0K | -$1.6K | -$0.24 | 1 |
| Mar 2026 | $40.0K | $40.0K - $40.0K | -$16.0K | -$0.40 | 1 |
| Mar 2025 | $25.0K | $25.0K - $25.0K | -$10.0K | -$1.48 | 1 |
| Mar 2024 | $1.40M | $1.40M - $1.40M | -$560.0K | -$1.90 | 1 |
| Mar 2023 | $200.0K | $200.0K - $200.0K | -$80.0K | -$3.70 | 1 |